Akcea Therapeutics Promotes Damien McDevitt to CEO

20:56 EDT 26 Mar 2020 | Xconomy

Akcea Therapeutics (NASDAQ: AKCA) has appointed Damien McDevitt as its chief executive officer, the company announced Tuesday. Akcea, a subsidiary of Carlsbad, CA-based Ionis Pharmaceuticals (NASDAQ: IONS), is advancing a group of experimental rare disease drugs discovered by its parent company. McDevitt had been serving as Akcea’s interim CEO since September 2019, when CEO Paula Soteropoulos, president […]

Original Article: Akcea Therapeutics Promotes Damien McDevitt to CEO


More From BioPortfolio on "Akcea Therapeutics Promotes Damien McDevitt to CEO"

Quick Search

Relevant Topic

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...